Rapidly growing, moderately differentiated HCC: A clinicopathological characteristic of HCC occurrence after IFN-free DAA therapy?
Authors:
Open Access
- 1 April 2018
- journal article
- letter
- Published by Elsevier in Journal of Hepatology
- Vol. 68 (4) , 854-855
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis CPLOS ONE, 2017
- DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV TreatmentPLOS ONE, 2016
- Report of the 19th follow‐up survey of primary liver cancer in JapanHepatology Research, 2016
- Tumor marker doubling time can be useful as a prognostic marker for hepatocellular carcinomaKanzo, 2014
- Serological and histological indices of hepatocellular carcinoma and tumor volume doubling timeMolecular and Clinical Oncology, 2013
- Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinomaJournal of Surgical Oncology, 2009
- Pathology of early hepatocellular carcinoma: Progression from early to advancedSeminars in Surgical Oncology, 1996